ADRESSING ISSUES FACING PROSTATE CANCER PATIENTS
Managing Prostate Cancer Survivorship Meetings
WATCH:
Beating the Odds: Turning a Stage IV Diagnosis Into a Survivorship Plan
"Knowledge is the Best Defense Against Prostate Cancer."
PHEN church partners and their members can access free resources online and order materials for distribution.
Join the PHEN Team every month with a new topic surrounding prostate cancer survivorship.
Every month, PHEN brings in leading doctors and survivors to discuss issues facing prostate cancer patients. You will also be shown how to use the many tools and resources PHEN offers to help empower you along your prostate cancer journey.
This month we are discussing “Treatment Options Update for Newly Diagnosed and for Patients with Recurrent Prostate Cancer”. Staying current with treatment options is now more critical than ever. Join PHEN for a presentation that provides treatment updates using the new version of PHENPath.com which is based upon the 2025 National Comprehensive Cancer Network (NCCN) Treatments Guidelines.
Who Should Attend
- Men living with prostate cancer, newly diagnosed or long‑term survivors
- Family members, partners, and friends who help with care.
- Community health workers, clergy, nurses, and primary‑care providers
What You Will Learn
- Two main stages of advanced prostate cancer mHSPC (Metastatic hormone-sensitive prostate cancer) and mCRPC (Metastatic castration-resistant prostate cancer) sound alike, but they call for different drugs and have different outlooks.
- Key changes in the 2025 NCCN Guidelines using PHENPATH.com
- PHENPath.com demo: See quick comparison charts, “Ask‑Your‑Doctor” checklists, and a new Survivorship Corner on diet, exercise, sexual health, and emotional support.
- Must ask questions: Key points on side-effect management, treatment sequencing, and clinical-trial access, so you can advocate for the best possible care.
Date & Time
- Jul 9, 2025 06:00 PM
- Aug 13, 2025 06:00 PM
- Sep 10, 2025 06:00 PM
- Oct 8, 2025 06:00 PM
- Nov 12, 2025 06:00 PM
- Dec 10, 2025 06:00 PM
Time shows in Eastern Standard Time
Speakers
Keith Crawford, MD, PhD
Director of Clinical Trials and Patient Education • PHEN
Dr. Keith Crawford joined PHEN in 2019. As director of clinical trials and patient education, he is responsible for implementing programs in these areas as well as working with patients and PHEN partners.
Dr. Crawford has more than 20 years of experience in the Life Sciences and completed his graduate and post-graduate training at Harvard Medical School where he developed competencies in the area of genomics, proteomics, immunology, microbiology, infectious diseases, and regenerative medicine.
During his post-doctoral training, Keith was selected by the Robert Wood Johnson Foundation as a Harold Amos Fellow. His work in the field of immunology caught the eye of the Department of Defense where he received funding to develop antidotes for chemical and biological weapons exposure as well as create a high throughput platform for the detection of biological weapons and emerging infectious agents.
After completing this directive, Dr. Crawford became the director of the Center for Molecular Orthopedics at Brigham and Women’s Hospital. He was responsible for leading research efforts at the center, which gave rise to the discovery of a novel population of early lineage adult stem cells. Dr. Crawford and his colleagues were responsible for the preclinical studies, which laid the foundation for a spinal fusion therapeutic.
Dr. Crawford is a graduate of Prairie View University, the University of Texas Medical School in Houston (Medical Doctorate), and Harvard University (Doctor Philosophy) where he studied cell biology and immunology.
Partners
